205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-3.77%
Revenue decline while MCHP shows 15.39% growth. Joel Greenblatt would examine competitive position erosion.
0.54%
Cost growth less than half of MCHP's 10.78%. David Dodd would verify if cost advantage is structural.
-7.59%
Gross profit decline while MCHP shows 18.38% growth. Joel Greenblatt would examine competitive position.
-3.97%
Margin decline while MCHP shows 2.60% expansion. Joel Greenblatt would examine competitive position.
7.65%
R&D growth less than half of MCHP's 16.13%. David Dodd would verify if efficiency advantage is sustainable.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
101.41%
Other expenses change of 101.41% while MCHP maintains costs. Bruce Berkowitz would investigate efficiency.
28.13%
Operating expenses growth above 1.5x MCHP's 15.44%. Michael Burry would check for inefficiency.
8.24%
Total costs growth 50-75% of MCHP's 12.75%. Bruce Berkowitz would examine efficiency.
No Data
No Data available this quarter, please select a different quarter.
-2.94%
D&A reduction while MCHP shows 14.27% growth. Joel Greenblatt would examine efficiency.
-21.68%
Both companies show EBITDA decline. Martin Whitman would check industry conditions.
-18.61%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-26.18%
Operating income decline while MCHP shows 20.51% growth. Joel Greenblatt would examine position.
-23.28%
Operating margin decline while MCHP shows 4.44% growth. Joel Greenblatt would examine position.
-44.44%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-26.44%
Pre-tax income decline while MCHP shows 22.25% growth. Joel Greenblatt would examine position.
-23.56%
Pre-tax margin decline while MCHP shows 5.95% growth. Joel Greenblatt would examine position.
-17.65%
Tax expense reduction while MCHP shows 58.47% growth. Joel Greenblatt would examine advantage.
-29.30%
Net income decline while MCHP shows 18.24% growth. Joel Greenblatt would examine position.
-26.53%
Net margin decline while MCHP shows 2.47% growth. Joel Greenblatt would examine position.
-29.11%
EPS decline while MCHP shows 20.00% growth. Joel Greenblatt would examine position.
-28.57%
Diluted EPS decline while MCHP shows 20.00% growth. Joel Greenblatt would examine position.
-0.43%
Share count reduction while MCHP shows 0.47% change. Joel Greenblatt would examine strategy.
0.42%
Diluted share reduction exceeding 1.5x MCHP's 2.44%. David Dodd would verify capital allocation.